HIGHLIGHTS
- who: Juan-Manuel Sancho from the (UNIVERSITY) have published the research work: IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice, in the Journal: (JOURNAL)
- what: The study was approved by the Ethics Committee (EC) of the participating centers and conducted following the Helsinki Declaration and national regulations. This was probably due to fewer patients receiving ibrutinib in second-line of therapy than in later lines, and to the low number of patients in this study to perform comparisons per line of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.